Hofseth North America

Hofseth North America is the regional subsidiary of Hofseth BioCare ASA, a Norwegian biotechnology company focused on the sustainable upcycling of Atlantic salmon by-products. The company utilizes a proprietary enzymatic hydrolysis platform to produce high-value bioactive ingredients, including salmon oil (OmeGo), protein hydrolysates (ProGo), and bone calcium (CalGo). These products are clinically studied for their effects on respiratory health, iron deficiency anemia, and age-related muscle loss. Hofseth North America manages the commercialization and distribution of these ingredients for the human and animal health markets in the United States and Canada. The company's research-driven approach aims to provide natural, traceable alternatives to synthetic supplements while promoting a circular economy. Their clinical pipeline includes ongoing investigations into the anti-inflammatory properties of salmon oil for conditions like asthma and COVID-19.